(Q48510554)
Statements
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All) (English)
Roberta Bortolozzi
Luca Trentin
Benedetta Accordi
3 February 2018
scientific article